Publication of Prospectus

RNS Number : 3089N

Catlin Group Limited

13 February 2009

 



13 February 2009

This announcement is not for publication or distribution, directly or indirectly, in or into the United States, Canada, Australia, New Zealand, Japan, South Africa or any other jurisdiction in which the same would be unlawful

Catlin Group Limited

PUBLICATION OF PROSPECTUS

The following prospectus has been submitted to the UK Listing Authority and is available for inspection at 
their Document Viewing Facility at the Financial Services Authority, 25 North Colonnade, Canary Wharf, 
London, E14 5HS:  

Prospectus dated 12 February 2009 relating to a 2 for 5 Rights Issue of up to 106,643,145 New 
Common Shares at 205 pence each.

Two copies of the Circular, Form of Proxy and Form of Direction have been forwarded to the Document 
Viewing Facility.

The Prospectus, Circular, Form of Proxy and Form of Direction will be available shortly in electronic form
on the Company's website at www.catlin.com.

Terms defined in the Prospectus have the same meanings in this announcement.  

 This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Nil Paid Rights, New Common Shares or New Depositary Interests and shall not form the basis of, or be relied upon in connection with, any contract to purchase or subscribe for any Nil Paid Rights, New Common Shares or New Depository Interests. Past performance is no guide to future performance and any investment decision to take up or buy Nil Paid Rights, New Common Shares or (in the case of Depositary Interest Holders only) New Depositary Interests must be made solely on the basis of publicly available information. Persons needing advice should consult an independent financial adviser.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States, Canada, Australia, New Zealand, Japan, South Africa or any jurisdiction in which the same would be unlawful. This announcement is for information only and does not constitute an offer or invitation to take up, acquire or dispose of Nil Paid Rights, New Common Shares or New Depositary Interests in the United States or any jurisdiction in which the same would be unlawful. The New Common Shares, the Nil Paid Rights and the New Depositary Interests have not been and will not be registered under the U.S. Securities Act of 1933, as amended, (the 'Securities Act') and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. . The distribution of this announcement and the offering or sale of the Nil Paid Rights, New Common Shares or New Depositary Interests in certain jurisdictions may be restricted by law. No action has been taken by the Company, JPMorgan Cazenove, JPMSL or UBS that would permit an offering of such Nil Paid Rights, New Common Shares or New Depositary Interests or possession or distribution of this announcement or any other offering or publicity material relating to such Nil Paid Rights, New Common Shares or New Depositary Interests in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company, JPMorgan Cazenove, JPMSL and UBS to inform themselves about, and to observe, any such restrictions.

This announcement is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by JPMorgan Cazenove, JPMSL or UBS or by any of their respective affiliates or agents as to or in relation to, the accuracy or completeness of this announcement, or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is hereby expressly disclaimed.

JPMorgan Cazenove, which is authorised and regulated by the FSA, is acting for the Company in connection with the Rights Issue and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to clients of JPMorgan Cazenove nor for providing advice in relation to the Rights Issue.

JPMSL, which is authorised and regulated by the FSA, is acting for the Company in connection with the Rights Issue and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to clients of JPMSL nor for providing advice in relation to the Rights Issue.

UBS is acting for the Company in connection with the Rights Issue and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to clients of UBS nor for providing advice in relation to the Rights Issue. 

 

END

 

 

PDIZXLFFKLBXBBK